| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |